EUAs: What’s Available Inpatient? Part 2

In the global effort to address the COVID-19 pandemic, healthcare practitioners need to stay up to date as the Emergency Use Authorization (EUAs) for treatments and vaccines change rapidly. This 6-part podcast series opens with a discussion of how EUAs work and how they are different from full approval. In the subsequent episodes, experts explain the latest evidence-based information on inpatient and outpatient antiviral treatments, the most recent information on available vaccines, and how the emerging SARS-CoV-2 variants impact our COVID-19 toolbox.In this second half of a discussion about treatments for COVID-19 in the hospital setting, an expert explains the use of dexamethasone, including insights on the choice of steroids to treat COVID-19 in pregnancy. The conversation then moves to other immune modulators, tocilizumab and the combination of baricitinib plus the antiviral remdesivir, and includes an overview of the evidence on efficacy and safety.Claim your credit at pce.is/COV19.